| 000 | 01813 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517155720.0 | ||
| 264 | 0 | _c20180319 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1178-2005 | ||
| 024 | 7 |
_a10.2147/COPD.S135338 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaddi, Satyanarayana | |
| 245 | 0 | 0 |
_aAmpicillin resistance in _h[electronic resource] |
| 260 |
_bInternational journal of chronic obstructive pulmonary disease _c2017 |
||
| 300 |
_a1507-1518 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmpicillin _xtherapeutic use |
| 650 | 0 | 4 |
_aAmpicillin Resistance _xgenetics |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDisk Diffusion Antimicrobial Tests |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHaemophilus Infections _xdiagnosis |
| 650 | 0 | 4 |
_aHaemophilus influenzae _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPneumonia, Bacterial _xdiagnosis |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aKolsum, Umme | |
| 700 | 1 | _aJackson, Sarah | |
| 700 | 1 | _aBarraclough, Richard | |
| 700 | 1 | _aMaschera, Barbara | |
| 700 | 1 | _aSimpson, Karen D | |
| 700 | 1 | _aPascal, Thierry G | |
| 700 | 1 | _aDurviaux, Serge | |
| 700 | 1 | _aHessel, Edith M | |
| 700 | 1 | _aSingh, Dave | |
| 773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 12 _gp. 1507-1518 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S135338 _zAvailable from publisher's website |
| 999 |
_c27244364 _d27244364 |
||